TELA Bio, Inc. (NASDAQ:TELA) Q3 2022 Results Conference Call November 9, 2022 4:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group Tony Koblish - President and CEO Roberto Cuca - COO and CFO Conference Call Participants Frank Takkinen - Lake Street Capital Markets Phil Dantoin - Piper Sandler Kyle Rose - Canaccord Genuity Dave Turkaly - JMP Securities Zach Weiner - Jefferies Operator Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Third Quarter 2022 Earnings Conference Call. [O ...

For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39130 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 TELA Bio, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other juri ...

8 INVESTOR PRESENTATION August 2022 Forward Looking Statements This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this document, including but not limited to statements regarding possible or assumed future results of operations, business strategies, development plans, regulatory activities, market opportunity competitive position, potential growth opportunities ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39130 TELA Bio, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdict ...

TELA Bio, Inc. (NASDAQ:TELA) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Louisa Smith – Gilmartin Group Tony Koblish – President and Chief Executive Officer Roberto Cuca – Chief Operating Officer and Chief Financial Officer Conference Call Participants Frank Takkinen – Lake Street Capital Markets Caitlin Cronin – Canaccord Matthew O'Brien – Piper Sandler Dave Turkaly – JMP Securities Operator Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Second Quarte ...

TELA Bio, Inc. (NASDAQ:TELA) Q1 2022 Results Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Louisa Smith - Investor Relations Antony Koblish - President and Chief Executive Officer Roberto Cuca - Chief Operating Officer and Chief Financial Officer Conference Call Participants Zachary Weiner - Jefferies David Turkaly - JMP Securities Operator Good afternoon, ladies and gentlemen, and welcome to the TELA Bio First Quarter 2022 Earnings Conference Call. [Operator Instructions] As a remi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37526 TELA Bio, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdic ...

Table of Contents ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) For the transition period from to Commission file number: 001-37526 TELA Bio, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction ...

TELA Bio, Inc. (NASDAQ:TELA) Q4 2021 Earnings Conference Call March 21, 2022 4:30 PM ET Company Participants Louisa Smith - Investor Relations Tony Koblish - President and Chief Executive Officer Roberto Cuca - Chief Operating Officer and Chief Financial Officer Conference Call Participants Drew Stafford - Piper Sandler Kyle Rose - Canaccord Zach Weiner - Jefferies Dave Turkaly - JMP Securities Operator Good afternoon, ladies and gentlemen and welcome to the TELA Bio Fourth Quarter 2021 Earnings Conference ...

TELA Bio, Inc. (NASDAQ:TELA) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Hannah Jeffrey - The Gilmartin Group Tony Koblish - President and Chief Executive Officer Roberto Cuca - Chief Operating Officer and Chief Financial Officer Conference Call Participants Andrew Stafford - Piper Sandler Frank Pinal - Jefferies Kyle Rose - Canaccord Genuity David Turkaly - JMP Securities Operator Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Third Quarter 2021 E ...